His clinical interests include all forms of primary brain tumors, consultative support for patients with systemic cancer that involve the central nervous system and difficult general neurology cases. He is working on the future establishment of a comprehensive care experience for patients with glioblastoma centering around data generated from the deep sequencing of the exome and genome of the tumor to guide personalized chemotherapy regimens. Dr. Becker’s current research focuses on bringing novel treatments to clinical trial for patients with primary brain tumors. He completed his medical degree at University of South Carolina College of Medicine, his residency in neurology at Yale-New Haven Hospital and a fellowship in neuro-oncology at Yale School of Medicine.